Keyphrases
1-year-olds
19%
Adverse Drug Events
19%
Allergy
39%
Antidiabetic Drugs
39%
Asthma
19%
Beliefs about Medicines Questionnaire
39%
Cardiovascular Disease
9%
Cardiovascular Risk
28%
Chronic Disease
58%
Comprehensibility
16%
Counseling
19%
Decision Aid
58%
Diabetes
19%
Discrete Choice Experiment
19%
Drug Characteristics
16%
Drug Class
25%
Drug Effects
58%
During Pregnancy
39%
Epilepsy
39%
Europe
19%
European Countries
19%
Gastrointestinal
29%
Glucose-lowering Drugs
58%
High-score
19%
Hypoglycemic Events
29%
Inflammatory Bowel Disease
39%
Maximum Acceptable Risk
58%
Medication Beliefs
58%
Medication Use
19%
Medicine Acceptability
29%
Multinomial Logit Model
9%
Netherlands
58%
No Significant Difference
19%
Patient Preference
28%
Positive Beliefs
19%
Preference Study
58%
Pregnant Women
58%
Regulatory Decisions
9%
Relative Weight
58%
Rheumatic Diseases
19%
Risk Reduction
19%
Shared Decision Making
16%
Treatment Decisions
19%
Turkey
58%
Type 2 Diabetes Mellitus (T2DM)
78%
Type 2 Diabetic Patients
67%
Web-based
16%
Web-based Study
58%
Web-based Survey
19%
Women with children
19%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
58%
Adverse Event
58%
Alzheimer's Disease
58%
Antidiabetic Agent
44%
Bladder Cancer
14%
Cardiovascular Disease
44%
Cardiovascular Disease
9%
Combination Therapy
58%
Cross Sectional Study
52%
Disease
8%
Disease Exacerbation
8%
Drug Safety
58%
Glucagon-Like Peptide-1
9%
Hemoglobin A1c
14%
Hypoglycemia
9%
Metformin
9%
Non Insulin Dependent Diabetes Mellitus
58%
Non Insulin Dependent Diabetes Mellitus
58%
Oral Antidiabetic Agent
58%
Pharmacovigilance
29%
Risk Communication
29%
Sodium Glucose Cotransporter 2 Inhibitor
58%
Nursing and Health Professions
Adverse Event
58%
Allergic Asthma
5%
Alzheimer's Disease
88%
Cardiovascular Disease
11%
Chronic Disease
88%
Clinical Practice
29%
Combination Therapy
58%
Confidence Interval
16%
Cross-Sectional Study
5%
Disease
31%
Disease Exacerbation
8%
Drug Therapy
100%
Glucagon Like Peptide 1
11%
Hypoglycemia
11%
Inflammatory Bowel Disease
11%
Metformin
11%
Non Insulin Dependent Diabetes Mellitus
58%
Patient Preference
11%
Patient with Type 2 Diabetes
70%
Practice Guideline
11%
Rheumatic Disease
5%
Shared Decision-Making
23%
Thematic Analysis
11%